SEC Form 4 · accession 0001179110-16-033000
Celldex Therapeutics, Inc. · CLDX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Gerald McMahon Ph.D.
Director
Period of report
Dec 14, 2016
Accepted (ET)
Dec 15, 2016 · 4:08 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000744218
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Non-Qualified Stock Otion (right to buy)F1,F2 | $3.72 | Dec 14, 2016 | A | 8,000 | A | — | Dec 14, 2026 | Common Stock | 8,000 | 8,000 | D |
Explanation of responses
- F1Represents option granted by the Issuer pursuant to its 2008 Stock Option and Incentive Plan.
- F2100% of the total amount of shares subject to the Option vests on December 14, 2017.